Product Information:

ZOLID 15mg Tablets contain Pioglitazone Hydrochloride 15mg, a thiazolidinedione (TZD) class oral antidiabetic agent. It works by activating peroxisome proliferator-activated receptor-gamma (PPAR-γ) in fat, muscle, and liver tissues, which enhances insulin sensitivity and reduces insulin resistance—a core defect in type 2 diabetes.

This low-strength formulation is commonly used as a starting dose or for patients requiring cautious titration due to comorbidities or risk factors.

Uses of (ZOLID 15MG TABLETS):

1. Monotherapy or adjunctive treatment of type 2 diabetes mellitus in adults
2. Patients with significant insulin resistance not adequately controlled by diet, exercise, or other agents
3. Combination therapy with metformin, sulfonylureas, or insulin when additional glycemic control is needed

Key Benefits of (ZOLID 15MG TABLETS):

1. Improves insulin sensitivity in peripheral tissues and liver
2. Reduces fasting and postprandial blood glucose levels
3. May help preserve pancreatic beta-cell function over time
4. Weight-neutral or modest weight gain (less than older TZDs like rosiglitazone)

How To Use (ZOLID 15MG TABLETS):

1. Take once daily, with or without food, at the same time each day.
2. Swallow whole with water—do not crush or chew.
3. Typical dosing:
4. Starting dose: 15mg once daily
5. Maintenance: May be increased to 30mg or 45mg once daily after 8–12 weeks if HbA1c remains above target
6. Continue diet, exercise, and regular blood glucose monitoring.

When Not to Use (ZOLID 15MG TABLETS):

Do not use if you have:

1. Type 1 diabetes or diabetic ketoacidosis
2. Active liver disease or elevated ALT >2.5× upper limit
3. History of bladder cancer (pioglitazone may increase risk)
4. Heart failure (NYHA Class III or IV)
5. Hypersensitivity to pioglitazone or any excipients

⚠️ Important: Pioglitazone is not recommended in patients with active or prior bladder cancer.

Side Effects of (ZOLID 15MG TABLETS):

Common:

1. Weight gain (dose-dependent)
2. Mild edema (swelling in legs/ankles)
3. Headache, upper respiratory infection

Less common:

1. Bone fractures (especially in postmenopausal women)
2. Mild anemia
3. Elevated liver enzymes

Serious (rare but require monitoring):

1. Worsening heart failure (shortness of breath, rapid weight gain, fatigue)—discontinue if occurs
2. Bladder cancer (hematuria, dysuria, urgency)—risk increases with prolonged use (>1 year)
3. Hepatotoxicity (jaundice, dark urine, abdominal pain)—monitor LFTs before and during therapy
4. Seek medical help if signs of heart failure, blood in urine, or yellowing of skin/eyes occur.

Dosage: (ZOLID 15MG TABLETS):

1. Adults: Start at 15mg once daily
2. Maximum dose: 45mg once daily
3. Elderly or hepatic impairment: Start at 15mg; avoid if severe liver disease
4. Renal impairment: No dose adjustment needed (not renally excreted)

Who It’s For (ZOLID 15MG TABLETS):

Adults with type 2 diabetes who exhibit significant insulin resistance and have no contraindications to thiazolidinediones, particularly those unable to tolerate metformin or requiring add-on therapy.

Warnings & Precautions:

1. Monitor liver function tests (LFTs) before starting and periodically thereafter
2. Assess for signs of heart failure at each visit
3. Screen for bladder cancer in patients with hematuria or history of smoking
4. Use caution in postmenopausal women (increased fracture risk)
5. Avoid in patients with macular edema (may worsen)

Drug Interactions:

1. Gemfibrozil: ↑ Pioglitazone levels—avoid combination
2. Rifampin: ↓ Pioglitazone efficacy—monitor glucose
3. Insulin or sulfonylureas: May increase hypoglycemia risk
4. Always inform your doctor about all medications and supplements.

Additional Information:

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children. Do not use after the expiration date. Available by prescription in Pakistan.